Benzyl isothiocyanate (BITC) inhibits migration and invasion of human gastric cancer AGS cells via suppressing ERK signal pathways.

Department of Nursing, Central Taiwan University of Science and Technology, Taichung, Taiwan.
Human & Experimental Toxicology (Impact Factor: 1.31). 05/2010; 30(4):296-306. DOI: 10.1177/0960327110371991
Source: PubMed

ABSTRACT Metastasis suppressors and associated other regulators of cell motility play a critical initial role in tumor invasion and metastases. Benzyl isothiocyanate (BITC) is a hydrolysis compound of glucotropaeolin in dietary cruciferous vegetables. BITC has been found to exhibit prevention of cancers in laboratory animals and might also be chemoprotective in humans. Here, the purpose of this study was to investigate the effects of BITC on cell proliferation, migration, invasion and mitogen-activated protein kinase (MAPK) pathways of AGS human gastric cancer cells. Wound healing and Boyden chamber (migration and invasion) assays demonstrated that BITC exhibited an inhibitory effect on the abilities of migration and invasion in AGS cancer cells. BITC suppressed cell migration and invasion of AGS cells in a dose-dependent manner. Results from Western blotting indicated that BITC exerted an inhibitory effect on the ERK1/2, Ras, GRB2, Rho A, iNOS, COX-2 for causing the inhibitions of MMP-2, -7 and -9 then followed by the inhibitions of invasion and migration of AGS cells in vitro. BITC also promoted MKK7, MEKK3, c-jun, JNK1/2, VEGF, Sos1, phosphoinositide 3-kinase (PI3K), PKC, nuclear factor-kappaB (NF-κB) p65 in AGS cells. Results from real-time polymerized chain reaction (PCR) showed that BITC inhibited the gene expressions of MMP-2,-7 -9, FAK, ROCK1 and RhoA after BITC treatment for 24 and 48 hours in AGS cells. Taken together, the finding may provide new mechanisms and functions of BITC, which inhibit migration and invasion of human gastric cancer AGS cells.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The relationship between the cruciferous vegetables (CV) consumption and risk of gastric cancer has been investigated by many studies but is controversial. We performed a meta-analysis to summarize available evidence from epidemiological studies on this point. Relevant published studies of CV intake and gastric cancer were identified using MEDLINE (PubMed), EMBASE, and Web of Science databases through the end of September 2012. We pooled the relative risks (RRs) from individual studies using a fixed- or random-effects model and performed heterogeneity and publication bias analyses. Sixteen case-control and 6 prospective studies were included in our analysis. When all studies were pooled, we yielded a significantly inverse association between CV (RR=0.81; 95% confidence interval 0.75-0.88) intake and gastric cancer risk, with little heterogeneity (Q=27.27, P=0.292, I(2) =12.0%). Specific analysis for cabbage intake yielded similar result. When separately analyzed, case-control studies of CV intake yielded significant results and the results of prospective studies showed borderline statistical significance. Moreover, significant results were consistent for high-quality studies, for American, European and Asian studies, for studies on males, and for studies on non-cardia gastric cancer. Findings from this meta-analysis provide evidence that high intake of CV was inversely associated with the risk of gastric cancer and non-cardia gastric cancer in humans. Further studies on other specific CV, food-preparation methods, stratified results by anatomic cancer site and histological type should be extended in future. This article is protected by copyright. All rights reserved.
    Cancer Science 05/2013; · 3.48 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Campylobacter jejuni is a widespread pathogen responsible for most of the food-borne gastrointestinal diseases in Europe. The use of natural antimicrobial molecules is a promising alternative to antibiotic treatments for pathogen control in the food industry. Isothiocyanates are natural antimicrobial compounds, which also display anti-cancer activity. Several studies described the chemoprotective effect of isothiocyanates on eukaryotic cells, but the antimicrobial mechanism is still poorly understood.We investigated the early cellular response of C. jejuni to benzylisothiocyanate by both transcriptomic and physiological approaches. The transcriptomic response of C. jejuni to benzylisothiocyanate showed upregulation of heat shock response genes and an impact on energy metabolism. The oxygen consumption was progressively impaired by benzylisothiocyanate treatment as revealed by high-resolution respirometry, while the ATP content increased soon after benzylisothiocyanate exposition, which suggests a shift in the energy metabolism balance. Finally, benzylisothiocyanate induced intracellular protein aggregation. These results indicate that benzylisothiocyanate affects C. jejuni by targeting proteins, resulting in the disruption of major metabolic processes and eventually leading to cell death.
    Applied and Environmental Microbiology 09/2013; · 3.95 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Crude extract of Rheum palmatum L. (CERP) has been used to treat different diseases in the Chinese population for decades. In this study, we investigated the anti-metastasis effects of CERP on LS1034 human colorectal cancer cells in vitro and examined potential mechanisms of its effects. CERP significantly inhibited cell migration and invasion of LS1034 cells. We also found that CERP inhibited protein levels of matrix metalloproteinases-2 (MMP-2) and matrix metalloproteinases-9 (MMP-9), and cytosolic NF-kB p65, RHO A, ROCK 1. Furthermore, we found CERP inhibited protein levels of GRB2, SOS1, MKK7, FAK, Rho A, ROCK 1, VEGF, PKC, AKT, phosphor-AKT (Thr308), Cyclin D, iNOS, COX2, NF-kB p65, p-ERK1/2, p-JNK1/2, p-p38, p-c-jun, MMP-2, MMP-9, MMP-1, MMP-7, MMP-10, UPA and increased the protein level of Ras in LS1034 cells. In conclusion, our results suggest that CERP may be used as a novel anti-metastasis agent for the treatment of human colon cancer cells. © 2014 Wiley Periodicals, Inc. Environ Toxicol, 2014.
    Environmental Toxicology 02/2014; · 2.71 Impact Factor


Available from